NEW FDA APPROVED DRUGS FOR THE TREATMENT FOR ATOPIC DERMATITIS

Journal Title: World Journal of Pharmaceutical and life sciences - Year 2018, Vol 4, Issue 4

Abstract

Atopic Dermatitis (AD) is a highly pruritic chronic inflammatory skin disease that commonly presents during early childhood. It is a special form of eczematous dermatitis with wide range of severity. Several studies indicate that the disease is very common in western world with lifetime prevalence in children of 10% to 20%. In most patients it occurs before 5 yrs and typically clears by adolescence. AD has an immunologic basis. Both innate and adaptive immune responses are impaired in AD patients. Intense pruritis is a hallmark of the disease which leads to extensive scratching and further breakdown of the skin barrier. Treatment of atopic eczema should be based on a “stepped-care plan” where treatments are stepped up or down depending on the assessment of the state of the child’s skin by the physician. Both topical and systemic treatments are given for eczema. Topical corticosteroids and calcineurin inhibitors are used as topical anti-inflammatory agents. Patients should be carefully instructed about the use of topical glucocorticoids to avoid side effects. Newer drugs used in treatment of AD are Crisaborole ointment and Dupilumab injection. FDA approved these drugs on 14th December 2016 and 28th March 2017 respectively.

Authors and Affiliations

Saerah Simon

Keywords

Related Articles

3 D PRINTING TECHNOLOGY: A NEW ERA IN MEDICINE

Three dimensional printing may open up a whole new chapter of opportunities for pharmaceutical research and bio-technology applications. Three dimensional printing (3D) is a method to make three dimensional objects by fu...

AN OPEN LABEL CLINICAL STUDY TO EVALUATE THE EFFICACY OF SEKA AND NASYA IN THE MANAGEMENT OF SHUSHKAKSHIPAKA W.S.R TO DRY EYES IN MENOPAUSAL WOMEN

Dry eye is a multifactorial ocular surface disease that causes ocular pain, discomfort and decreased visual acuity. It is more prevalent in the females and specifically in the menopausal and postmenopausal age group. Thi...

ISOLATION AND PARTIAL STRUCTURE OF A FLAVONOL FROM SUDANESE PSIDIUM GUAJAVA L.

Fruits, like guava, contain bioactive components and regular consumption of fruits has many health promoting properties. This study was carried out to investigate the flavonoids of the medicinally important species Psidi...

EVALUATION OF REJUVENATION EFFECT OF AMALAKI IN AGEING

Ayurveda is one of the ancient systems of medicine, which is not only a health care system but a form of life style adopted to maintain perfect balance and harmony within human existence. Indian traditional medicine prac...

SURVEILLANCE ON THE SHORT AND LONG TERM VARIATIONS OF pH IN THE LOWER AND UPPER ZONES OF A TROPICAL ESTUARY

Wetlands of India are estimated to be the repositories of aquatic biodiversity .Kerala is one of the green states of India and is well known for its wetlands. Kerala contain a few wetlands of International importance inc...

Download PDF file
  • EP ID EP655554
  • DOI -
  • Views 119
  • Downloads 0

How To Cite

Saerah Simon (2018). NEW FDA APPROVED DRUGS FOR THE TREATMENT FOR ATOPIC DERMATITIS. World Journal of Pharmaceutical and life sciences, 4(4), 114-121. https://europub.co.uk/articles/-A-655554